ICP
GILD icon

Impact Capital Partners’s Gilead Sciences GILD Stock Holding History

Impact Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Sell
1,678
-25
-1% -$3.29K 0.06% 268
2026
Q1 		$237K Buy
1,703
+37
+2% +$5.18K 0.07% 255
2025
Q4 		$204K Buy
+1,666
New +$202K 0.06% 269

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Impact Capital Partners's GILD Position: Q2 2026 in Review

Impact Capital Partners reduced its Gilead Sciences (GILD) stake by 1.5% in Q2 2026, selling an estimated $3.29K and leaving 1,678 shares worth $212K. The position accounts for 0.06% of the portfolio, ranked #268.

Impact Capital Partners first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $237K in Q1 2026. 588 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Impact Capital Partners held 1,678 shares of Gilead Sciences worth $212K as of Q2 2026.
  • Impact Capital Partners sold 25 Gilead Sciences shares in Q2 2026, an estimated $3.29K.
  • Gilead Sciences made up 0.06% of Impact Capital Partners's portfolio in Q2 2026, its #268 holding.
  • Impact Capital Partners first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Impact Capital Partners's Gilead Sciences position peaked at $237K in Q1 2026.
  • 588 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Impact Capital Partners's 13F filing for Q2 2026, filed 14 Jul 2026.